Henlius USA

Company snapshot

Henlius USA Inc., located in Milpitas, CA, focuses on developing and delivering high-quality, innovative, and affordable medicine to patients worldwide to treat a range of chronic and life-threatening diseases with a focus in oncology and autoimmune diseases. Henlius USA Inc., is affiliated with Shanghai Henlius Biotech, a global biopharmaceutical company established in 2010. Henlius’ diverse pipe

• 3 active pipeline program(s) linked via ClinicalTrials.gov.
• 3 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Henlius USA. Not investment advice.

• approval Jun 6, 2026

  Pharma bets on PD-1/VEGF bispecifics: Is lung cancer the wrong target?

Recent activity

Latest pipeline, patent, and corporate events for Henlius USA.

1. Jun 8, 2026 Clinical update

   HLX07+carboplatin+pemetrexed — Phase 2

2. Jun 5, 2026 Clinical update

   Azvudine — Phase 3

3. May 26, 2026 Clinical update

   HLX02 — Phase 3

View all clinical trial activity →

• What is Henlius USA?

  Shanghai Henlius Biotech is a biotech organization headquartered in CN. Primary therapeutic focus areas include SARS-CoV-2 Infection, Breast Cancer, HLX07, nsqNSCLC, High EGFR Expression. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to thi

• Is Henlius USA publicly traded?

  Henlius USA appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Henlius USA develop or market?

  We link 4 drug profile(s) where Henlius USA is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/shanghai-henlius-biotech#company-drugs.

• What are the latest developments for Henlius USA?

  In the last 12 months our linked public records show 3 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Henlius USA focus on?

  Henlius USA focuses on SARS-CoV-2 Infection, Breast Cancer, HLX07, nsqNSCLC, High EGFR Expression based on our analysis of their pipeline programs and drug development activities.